About this trial
SEMO is a multidisciplinary project (language sciences, cognitive psychology and neuropsychology, physical medicine and rehabilitation, neurology, speech-language pathology, functional neuroimaging and engineering sciences) that aims first, to test and develop a novel speech rehabilitation program designed for patients with non-fluent aphasia and, second, to better describe neural reorganization after successful recovery. To this end, the investigators will conduct a prospective monocentric cross-over study, including two cohorts of post-stroke aphasic patients and two control groups.
Eligibility criteria
Qualifiers
patients with non-fluent aphasia after lesion in the dominant hemisphere for language
native speakers of French
normal or corrected to normal vision
satisfying all criteria for the MRI examination
Disqualifiers
patients with comprehension deficits, hemi-spatial neglect or upper limb apraxia
Trial design
Treatments tested in this trial
- Enriched rehabilitation
- Simple rehabilitation
Treatment groups
Sponsors and collaborators
University Hospital, Grenoble
Lead sponsor
Laboratoire de Psychologie et NeuroCognition
Collaborator
GIPSA-LAB
Collaborator